Halting hyaluronidase hopping to maintain the integrity of Medicare drug price negotiation
J. Kim, A. S. Kesselheim, and B. N. Rome
Health care resource utilization and costs of patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapies across different settings of care: A real-world data analysis
A. R. Patel, K. Hasegawa, S. Pandya, L. Shi, C. Lau, X. Zhao, A. M. Near, and F. L. Locke
Comparative real-world survival of first-line atezolizumab, nivolumab, and pembrolizumab in older patients with metastatic non–small cell lung cancer
X. Xue, M. Loop, B. Johnson, S. Ngorsuraches, J. Zheng, and J. Qian
Cost-per-responder analysis of daratumumab, bortezomib, lenalidomide, and dexamethasone vs bortezomib, lenalidomide, and dexamethasone among transplant-eligible patients with newly diagnosed multiple myeloma
S. Gautam, L. Morrison, P. Thompson-Leduc, B. Moore, G. Wong, B. Macomson, V. Khare, N. Gupta-Werner, and R. Medhekar
Medication utilization patterns among patients with rheumatoid arthritis and coexisting autoimmune conditions
J. P. DeShazo, E. Moyneur, D. Audrey Djibo, C. N. McMahill-Walraven, A. B. Mendelsohn, and C. Lockhart
Pharmacist care for attention-deficit/hyperactivity disorder electronic medication refills: A cluster randomized trial
T. A. Lieu, D. Parry, A. deLaunay, E. M. Warton, S. Prausnitz, O. Ahmed, M. R. Mancha, E. Smallberg, C. Quesenberry, K. Lee, M. Reed, and The Permanente Medical Group Virtual Care Study Team
Impact of a pharmacy care management service on cardiometabolic medication adherence and resource use for Medicare Advantage beneficiaries
S. Hallinan, L. Lidsky, J. Benner, S. Jones, E. Smith, C. Manolis, C. B. Good, and N. K. Choudhry
Examining the association between medication adherence trajectories and disease-specific clinical outcomes: An analysis focusing on the drug classes included in Part D quality bonus payments
V. M. Pontinha, D. L. Dixon, N. V. Carroll, K. B. Farris, and D. A. Holdford
The association of direct-acting antiviral therapy with health care utilization and costs in patients with chronic hepatitis C virus infection: A systematic review of real-world studies in the United States
S. M. Karimi, S. Poursafargholi, Y. Bayan Mohamed, H. Zarei, M. Moghadami, M. Rose, M. Goldsby, W. Fu, and B. B. Little
Patient engagement in managed care pharmacy: Putting policy into practice
J. Vandigo, K. Lenz, E. Grace Tsiao, and K. Westrich
Unmanaged depression and chronic disease medication adherence in Medicare Advantage beneficiaries: A claims-based analysis
D. Nguyen, A. Bowe, A. Stepter, L. Chung, H. Wind, I. Poonawalla, and A. Hames
Trends in delivery of comprehensive medication reviews by race and ethnicity, 2013-2021
D. A. Shenoy, L. Wilson, J. Farley, L. DeGuzman, M. Snyder, A. B. Coe, L. E. Hines, N. Brandt, A. DeVries, and A. Hung
JMCP, November 2025, Volume 31, Number 11
Align your brand with 30 years of JMCP and advancing the conversation in managed care pharmacy. New advertising packages available through 2025 include:
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
